PeptideScanner retained ClinicalTrials.gov record NCT06106932 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-30, and PeptideScanner's reviewed identity mapping was leuprolide. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1